In Vitro Activity of Iclaprim Against Isolates in Two Phase 3 Clinical Trials (REVIVE-1 and -2) for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.02239-18
Full Text
Open PDFAbstract
Available in full text
Date
January 14, 2019
Authors
Publisher
American Society for Microbiology